Clinical Trials Sponsored by Repertoire Immune Medicines
Total 8 results
-
Repertoire Immune MedicinesTerminatedRPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and MelanomaMelanoma | Cervical Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Repertoire Immune MedicinesTerminatedMelanoma | Head and Neck Cancer | HPV-Related Malignancy | Melanoma (Skin) | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Lung Cancer, Nonsmall CellUnited States
-
Repertoire Immune MedicinesMerck Sharp & Dohme LLCTerminated
-
Immune Technologies & Medicine GmbHUnknown
-
Immune Targeting Systems LtdHammersmith Medicines ResearchCompletedInfluenzaUnited Kingdom
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)Active, not recruitingCMML | AML With Monocytic DifferentiationUnited States
-
Shenzhen Geno-Immune Medical InstituteGuilin Hospital of Chinese Traditional and Western MedicineRecruiting
-
Assistance Publique - Hôpitaux de ParisCancer Research and Personalized Medicine (Carpem); Laboratoire d'excellence...Unknown